Opportunity ledger / Dossier O-1368
Recurring need documented in 33 independent public source items.
First seen 2026-07-15 · Last updated 2026-09-14 · Recalculated daily
This dossier's trend factor is 2.0, capped at 2.0.
Post title: [TLDR] After 16 months of heavy daily use, I'm canceling my Claude Max Pro 20x subscription – it turned into a compliance machine that no longer reasons [via r/…
I'm canceling my Claude Max Pro 20x subscription –…
The public layer keeps only a minimal excerpt. Open the source for full context.
Post title: [TLDR] Switched to Claude a year ago and suddenly now it's a huge garbage. [via r/claude]
I'm thinking about canceling my subscription becau…
The public layer keeps only a minimal excerpt. Open the source for full context.
Unlock all 33 evidence items — free
Leave your email to unlock the full evidence chain — every qualifying item, quote and source link — for every dossier in this browser. That is the whole reward: no export, no file, no report. Free, and the weekly digest stays opt-in below.
✓ Unlocked — reloading…
Evidence linked to this dossier has received 2 human audits. Reviews may confirm or correct the original label. View quality history →
What this evidence does not show yet
This dossier already carries first-hand payment evidence. What it still cannot tell you: market size, how reachable these people are, or what it costs to acquire them.
Follow how this opportunity evolves
Every item traceable · free · we email you only when this market actually changes
Scoring summary
Evidence confidence = strength × evidence volume × source diversity × payment × competition × trend × 10. Counts use independent content items; only first-hand pain, current spend, explicit willingness to pay and concrete feature requests affect the score. Repeated posts by one author are discounted. Scoring and status changes follow deterministic rules.
“Payment-backed” means first-hand payment evidence exists in the record. It does not mean the business is worth building. “Fading” is a recency tag shown alongside any evidence level, not a lower level. Read the full methodology.